Ifp Advisors, Inc Aeterna Zentaris Inc. Transaction History

Ifp Advisors, Inc

7 transactions

Quarter	Operation	Price Per share	shares change
Q3 2021 Oct 06, 2021	SELL	$0.59 - $0.88 $0 - $0	0 Closed
Q2 2021 Jul 13, 2021	BUY	$0.83 - $1.14 $0 - $0	0 New
Q1 2021 Apr 30, 2021	BUY	$0.51 - $3.34 $0 - $0	0 New
Q4 2020 Jan 25, 2021	BUY	$0.3 - $0.44 $0 - $0	0 New
Q3 2020 Oct 29, 2020	BUY	$0.34 - $0.55 $0 - $0	0 New
Q2 2020 Aug 05, 2020	BUY	$0.45 - $1.2 $0 - $0	0 New
Q1 2020 May 12, 2020	BUY	$0.42 - $1.44 $0 - $0	0 New

Ticker AEZS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 4,855,880
Market Cap $19.4M
Description
Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests. Its lead product is macimorelin, an orally available peptidomimetic ghrelin receptor (GHSR-1a) agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a for the diagnosis of adult grow...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.